Two disciplines. One accountable standard
Clinical development and site execution, connected.
MDTrials is a Canadian clinical research company with two complementary service lines: MDTrials CRO, providing focused clinical-development and trial-execution support for sponsors, and MDTrials Sites, developing and managing Canadian clinical research sites. Either service can be engaged independently. When both support the same study, roles and oversight are defined and disclosed.
Why MDTrials exists
Clinical development and site execution are often planned in separate organizations, even though many delays and quality problems emerge at the interface between them. Protocol assumptions meet real clinic workflows. Country strategy meets site activation. Sponsor oversight meets the practical realities of recruitment, visits, documentation and investigator capacity.
MDTrials was built to connect those perspectives earlier — without blurring the responsibilities of the CRO and the investigational site.
Why us
Our Values
These commitments guide how MDTrials makes decisions when quality, growth, speed and commercial pressure pull in different directions.
Participants before programs
Participant safety and data integrity come before the commercial interests of MDTrials, the site or the sponsor. We do not treat that as a balance to negotiate; it is the hierarchy we apply when decisions are difficult.
Say the boundary out loud
We state material capability boundaries before they become commercial assumptions. Sponsors should know what we deliver directly, what requires qualified partners, and what sits outside our scope before work begins — not discover those limits during qualification or delivery.
Independence is structural, not promised
MDTrials CRO and MDTrials Sites operate under common ownership, which creates potential conflicts that cannot be managed by good intentions alone. We address them through separate legal entities and contracts, separation of conflicting study roles, documented governance, disclosure when both service lines support a study, and independent oversight where required.
Own the work, name the person
Every engagement has a named accountable lead for the contracted scope. Sponsors deal with people who understand the work, decisions have clear ownership, and escalation should make responsibility more visible — not less.
Earn the next site
We build research capability around established clinical practices and expand one site at a time. A site is presented to sponsors when it can pass feasibility honestly, not simply because a partnership has been signed. Growth that outruns our ability to support it is not responsible growth.
Our Commitments
Mission
MDTrials exists to make clinical research work where it actually happens — from sponsor decisions to site execution.
We provide focused clinical-development services and managed Canadian research sites to sponsors who need accountable execution, while building sustainable research capability inside the clinics where patients already receive their care.
Vision
A Canada where high-quality clinical research can reach the right patients and investigators without infrastructure being the limiting factor.
We want Canada to be easier for emerging biopharma to use as a clinical-development market, and for capable Canadian clinics to participate in research without having to build the operating infrastructure alone. We intend to help close both gaps — through focused clinical operations and by building research capability one site at a time.
Two ways to work with MDTrials
Selective by principle, not scale
Focused by design
We are deliberately narrower than a global full-service CRO and more selective than a network built for geographic scale alone. We define what we can execute, confirm capacity against the actual program, and state where specialist partners or external investigational sites are required. If we are not the right fit, we would rather say so before contracting.
Our strongest CRO and team experience is in oncology, inflammatory bowel disease and hepatology. MDTrials Sites has a distinct, site-level footprint currently anchored in inflammatory bowel disease and gastroenterology, with additional capabilities developed only as investigators, infrastructure and study demand support them.
Documented, not diffused
Built around accountable execution
MDTrials is structured for short escalation paths and visible ownership. Each engagement has a named accountable lead for the contracted scope. Quality, responsibilities and decisions are documented rather than absorbed into organizational layers, and technology is used to reduce administrative burden without replacing qualified review or accountability.
Leadership that has done the work
Founder & Chief Executive Officer
Murtaza Dahodwala founded MDTrials after working across both the site and CRO sides of clinical research. His experience includes Phase I oncology coordination in Canadian cancer and hospital settings, clinical trial monitoring in oncology, and management of device and health-technology studies in an academic research environment. That progression — coordinator, monitor, project manager and founder — shaped the operating model behind both MDTrials CRO and MDTrials Sites.
Murtaza Dohadwala
Separate entities, shared standard
One brand, defined responsibilities
MDTrials is the commercial brand used for two separate legal operating entities under common ownership. MDTrials CRO services are provided through Conduct Research Inc. MDTrials Sites services are provided through Searich Enterprises Inc.
Where both service lines participate in the same study, the relationship is disclosed and the applicable contracts, roles and oversight arrangements are defined separately.
Built to scale responsibly
Where we are going
We are building MDTrials by deepening capability before expanding claims: growing the Canadian site network one qualified relationship at a time, strengthening our core clinical-operations services, and building partner capacity where specialized functions are required. Public claims should grow only when the underlying operating capability is real and ready for sponsor qualification.
Planning a clinical program, evaluating Canadian execution, or looking for research-ready site capability? Start with the service line closest to the work.
Frequent Questions
- Can I engage MDTrials CRO without using MDTrials Sites?Yes. The two service lines can be engaged independently. Site selection remains the sponsor’s decision.
- Can MDTrials CRO and MDTrials Sites support the same study?Yes, when the study fits the managed network. The affiliation is disclosed, responsibilities are defined separately, and oversight arrangements are documented before work begins.
- Where is MDTrials based?MDTrials is based in Alberta, Canada. CRO services support Canadian clinical development and selected functional engagements, while the managed site network is currently anchored in Alberta and growing selectively.
CONTACT US
MDTrials brings together specialty CRO expertise and a growing Canadian site network under one brand, with clear responsibilities, senior involvement and a practical approach to clinical trial delivery.